Belatacept Is Associated with Improved Cardiovascular and Metabolic Risk Factors Compared to Cyclosporine in Kidney Transplant Patients (BENEFIT and BENEFIT-EXT Studies)
Year: 2009
Type: article
Source: Transplant International
Authors: Yves Vanrenterghem, Eduardo Mancilla-Urrea, Philippe Lang, Mamta Agarwal, A. Jay Block, J. Xing
Language: English
Subfield: Transplantation
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2519950240
